Summary of Job:
The Senior Medical Director, Global Medical Affairs – Oncology is responsible for leading the development and execution of global medical affairs strategies for oncology programs, with a focus on myeloid malignancies. This role provides medical and scientific leadership across assigned assets and supports the integration of medical strategies with broader corporate objectives. The incumbent will lead global medical activities related to evidence generation, scientific communication, and external engagement, including collaboration with alliance partners and key external stakeholders. The position works cross-functionally with Clinical Development, Commercial, Regulatory, Market Access, and other internal teams to ensure alignment and effective execution of medical affairs initiatives.
This role requires deep expertise in oncology and or hematology, strong strategic and analytical capabilities, and the ability to lead complex, cross-functional initiatives in a global environment.
Essential Functions:
- Lead the development and execution of global medical affairs strategies for assigned oncology assets, including pre-launch planning, lifecycle management, and long-term strategic initiatives focused on myeloid malignancies.
- Serve as the primary global medical scientific lead for healthcare decision-makers and external stakeholders, facilitating scientific exchange regarding disease state management and the clinical and economic value of oncology products.
- Collaborate cross-functionally with Clinical Development, Research & Development, HEOR, Market Access, Commercial, Regulatory, and other internal stakeholders to ensure alignment of medical strategies with corporate and portfolio objectives.
- Lead integrated evidence generation strategies and medical data generation plans, including company-sponsored clinical trials, investigator-sponsored studies, and real-world evidence initiatives.
- Provide strategic medical leadership for alliance partnerships by collaborating with partner companies to align on shared medical strategies, evidence generation activities, and external engagement plans across joint oncology programs.
- Oversee the execution and quality of ongoing medical affairs studies and activities to ensure scientific rigor, compliance with regulatory requirements, and alignment with organizational objectives.
- Identify evidence gaps, emerging scientific trends, and external insights to inform medical strategy, portfolio development, lifecycle planning, and stakeholder engagement activities.
- Build and maintain strategic relationships with key opinion leaders (KOLs), healthcare systems, advocacy organizations, payer organizations, and other external stakeholders globally.
- Represent the organization at scientific congresses, advisory boards, investigator meetings, and other external forums to communicate medical and scientific data and support organizational thought leadership in oncology.
- Coordinate global medical affairs activities with alliance partners and internal stakeholders to support seamless execution of shared medical initiatives and external engagement strategies.
- Provide leadership, coaching, and development for direct reports and/or junior medical affairs team members, including performance management, mentoring, and fostering a collaborative, high-performing team culture.
- Supervise and manage assigned personnel, consultants, vendors, and external collaborators, as applicable, to ensure effective execution of medical affairs objectives and adherence to company policies and compliance standards.
Job Requirements:
Education
Medical Doctor. Board certification and/or subspecialty training in Oncology and/or Hematology preferred.
Experience
- Minimum of 10 years of experience in Medical Affairs within the pharmaceutical and/or biotechnology industry, including significant experience in oncology; hematology and/or myeloid malignancy experience strongly preferred.
- Combination of Global and Regional/Country Medical Affairs experience strongly preferred, including experience supporting global product strategy and execution.
- Demonstrated experience developing and executing global medical affairs strategies across multiple stages of the product lifecycle, including pre-launch and post-launch activities.
- Proven track record of leading cross-functional initiatives and influencing matrixed teams across Medical Affairs, Clinical Development, Commercial, HEOR, Market Access, and Regulatory functions.
- Experience leading evidence generation activities, including company-sponsored studies, investigator-sponsored research, and/or real-world evidence initiatives.
- Demonstrated success engaging with external stakeholders, including key opinion leaders (KOLs), healthcare decision-makers, advocacy organizations, and payer audiences in global markets.
- Proven ability to collaborate effectively with alliance partners, external collaborators, and co-development/co-commercialization partners.
- Strong people leadership capabilities, including mentoring, coaching, and direct management of medical affairs personnel and/or cross-functional teams.
- Proven ability to represent the organization at scientific congresses, advisory boards, investigator meetings, and other external scientific forums.
- Strong knowledge of HEOR disciplines, biostatistics, clinical trial design, and evidence-based medicine principles.
- Exceptional interpersonal, communication, presentation, and organizational skills.
- Strategic thinking with demonstrated ability to influence stakeholders across matrix environments.
Technical Skills
- Strong knowledge of oncology medical affairs, including evidence generation, scientific exchange, and product lifecycle support within global markets.
- Advanced understanding of HEOR disciplines, biostatistics, clinical trial design, real-world evidence, and evidence-based medicine principles.
- Strong scientific acumen with the ability to interpret, analyze, and communicate complex clinical and scientific data to diverse stakeholder audiences.
Normal office environment with prolonged sitting and extensive computer work.
Requires up to 35% domestic and international travel
